LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Foot & Ankle/New Allograft Talocalcaneal Ligament Introduced
Foot & Ankle

New Allograft Talocalcaneal Ligament Introduced

January 13, 2020 2 min read Premium comments

Advertisement

New Allograft Talocalcaneal Ligament Introduced
Source: Wikimedia Commons and Henry Vandyke Carter
Secondary#arthrosurface#footandankleinstability#spiraluptclallograftsystem

Arthrosurface, Inc. recently introduced a new allograft talocalcaneal ligament for use in adult and teen patients who suffer from talocalcaneal instability, peritalar subluxation and other injuries that result in foot and ankle instability. The new allograft is brand named SpiralUp TCL Allograft System.

A healthy talocalcaneal ligament is essential to foot function by providing a layer of strong and flexible connective tissue. But when the doctor needs a replacement talocalcaneal ligament, there is now an allograft to meet that need—the SpiralUp TCL Allograft.

“The foot is the foundation of the body. When it or the gait cycle is compromised, an imbalance can be created throughout the body leading to strain and excessive wear of joints,” said Steve Ek company CEO in a statement.

“The SpiralUp TCL Allograft System represents yet another early intervention product in our portfolio that is designed to address the root cause of these types of problems and mitigate other cumulative effects throughout the musculoskeletal chain.”

Harold Schoenhaus, DPM, FACFAS, professor of The Temple University School of Podiatric Medicine, told OTW that patients who have ligamentous laxity, compensatory abnormal function of the subtalar and midtarsal joint, patients who toe-in, and those who have a tight Achilles are more prone to talocalcaneal instability and peritalar subluxation. Patients with congenital calcaneal valgus, knock-knee, posterior tibial dysfunction and those who have traumatic subluxation of the subtalar joint are all also more prone to talocalcaneal instability and peritalar subluxation.

On what makes the SpiralUp TCL Allograft System stand out from current standard of care, he said, “The biggest difference is that there is currently no procedure available that re-establishes the ligamentous integrity of the subtalar joint. The SpiralUp TCL Allograft is now the only system available that does this.”

“The relocation of subtalar instability requires ligamentous integrity to maintain the normal anatomic alignment of the talus to the calcaneus. By maintaining the subtalar stability, the midtarsal joint, primarily the talonavicular, relocation provides stability within the arch. Other procedures have attempted to block the motion between the talus and calcaneus which does not address the ligamentous instability. The SpiralUp TCL Allograft addresses all of these issues.”

Schoenhaus added, “Talocalcaneal instability and peritalar subluxation are progressive conditions with far-reaching symptoms and a vast patient population. After treating patients for over 45 years with these types of problems and symptoms, I envision the SpiralUp TCL Allograft System could be the most effective solution to alleviating these problems. It is intended to stabilize the subtalar and midtarsal joints while simultaneously addressing conditions such as arch, leg, knee and lower back discomfort.”

Arthrosurface, Inc., headquartered in Franklin, Massachusetts, specializes in joint preservation technology.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy